Use of Polysomnography for Non-Invasive Ventilation Settings' Optimization (NIV-OHS)
Primary Purpose
Obesity-Hypoventilation Syndrome (OHS)
Status
Unknown status
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
GoodKnight 425ST - Mallinckrodt DF, Tyco Healthcare
Sponsored by
About this trial
This is an interventional treatment trial for Obesity-Hypoventilation Syndrome (OHS)
Eligibility Criteria
Inclusion Criteria:
- Patient male or female, aged 20 to 75 years
- Patient with a OHS in stable condition, with a BMI> 32 kg/m2 and a PaCO2> 6 kPa in diurnal spontaneous breathing without other cause of alveolar hypoventilation
- Patient affiliated to a social security insurance
- Having given its written informed consent to participate to the study
Exclusion Criteria:
- Patients with inherent chronic obstructive pulmonary disease (COPD) with FEV1 on Forced Vital Capacity (FVC) ratio less than 70%
- Patients suffering from heart failure with periodic breathing
- Associated Neurological Diseases, evolving rapidly, leading to a dependency in daily activities
- Unbalanced Psychiatric Diseases
- Patients with a respiratory decompensation the month preceding the study
- Patients not autonomous in the use of the NIV
- Pacemaker patients, constituting a contraindication to magnetic stimulation
- Sensitive subjects, in accordance with article L 1121-6 of the French Public Health Code
- Patients with long term by steroids or other anti-inflammatory drugs
Sites / Locations
- Laboratoire d'Explorations Fonctionnelles Cardio-Respiratoires - CHU GrenobleRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
1
2
Arm Description
patients will benefit from a complete polysomnography under NIV
settings will be adjusted using only nocturnal oxygen SaO2 and PaCO2 at awakening whereas
Outcomes
Primary Outcome Measures
Diurnal PaCO2
Secondary Outcome Measures
Full Information
NCT ID
NCT00603096
First Posted
January 15, 2008
Last Updated
January 15, 2008
Sponsor
Tyco Healthcare Group
1. Study Identification
Unique Protocol Identification Number
NCT00603096
Brief Title
Use of Polysomnography for Non-Invasive Ventilation Settings' Optimization
Acronym
NIV-OHS
Official Title
Interest of Using Nocturnal Polysomnography for Non-Invasive Ventilation (NIV) Settings' Optimization in Obesity-Hypoventilation Syndrome (OHS)
Study Type
Interventional
2. Study Status
Record Verification Date
January 2008
Overall Recruitment Status
Unknown status
Study Start Date
June 2006 (undefined)
Primary Completion Date
June 2008 (Anticipated)
Study Completion Date
June 2008 (Anticipated)
3. Sponsor/Collaborators
Name of the Sponsor
Tyco Healthcare Group
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The aim of this randomized controlled trial is comparing the improvement of diurnal PaCO2 in OHS patients after one month of NIV treatment depending upon the tools used for adjusting settings. In one arm settings will be adjusted using only nocturnal oxygen SaO2 and PaCO2 at awakening whereas in the other arm patients will benefit from a complete polysomnography under NIV.
Detailed Description
Initiation of NIV treatment implies technical adjustments (choice of mask and ventilator), but also patient education by the nurses and medical staff. The settings are generally adjusted during the daytime in awake patients. The appropriateness of these settings is generally not optimal during sleep as many respiratory events (hypopnoea, apnea, leaks, desynchronization, and glottic closure) may occur under NIV then reducing the effectiveness of treatment. These nocturnal abnormalities are routinely evaluated by measuring their consequences, i.e. oxygen desaturation and the level of PaCO2 after wake up. Some teams are now proposing to better characterize what happens when using NIV during sleep using polysomnography (PSG). The precise characterization of residual events under treatment may allow optimizing ventilator settings.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity-Hypoventilation Syndrome (OHS)
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
45 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
1
Arm Type
Experimental
Arm Description
patients will benefit from a complete polysomnography under NIV
Arm Title
2
Arm Type
Active Comparator
Arm Description
settings will be adjusted using only nocturnal oxygen SaO2 and PaCO2 at awakening whereas
Intervention Type
Device
Intervention Name(s)
GoodKnight 425ST - Mallinckrodt DF, Tyco Healthcare
Intervention Description
The aim of this randomized controlled trial is comparing the improvement of diurnal PaCO2 in OHS patients after one month of NIV treatment depending upon the tools used for adjusting settings. In one arm settings will be adjusted using only nocturnal oxygen SaO2 and PaCO2 at awakening whereas in the other arm patients will benefit from a complete polysomnography under NIV.
Primary Outcome Measure Information:
Title
Diurnal PaCO2
Time Frame
June 2008
10. Eligibility
Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patient male or female, aged 20 to 75 years
Patient with a OHS in stable condition, with a BMI> 32 kg/m2 and a PaCO2> 6 kPa in diurnal spontaneous breathing without other cause of alveolar hypoventilation
Patient affiliated to a social security insurance
Having given its written informed consent to participate to the study
Exclusion Criteria:
Patients with inherent chronic obstructive pulmonary disease (COPD) with FEV1 on Forced Vital Capacity (FVC) ratio less than 70%
Patients suffering from heart failure with periodic breathing
Associated Neurological Diseases, evolving rapidly, leading to a dependency in daily activities
Unbalanced Psychiatric Diseases
Patients with a respiratory decompensation the month preceding the study
Patients not autonomous in the use of the NIV
Pacemaker patients, constituting a contraindication to magnetic stimulation
Sensitive subjects, in accordance with article L 1121-6 of the French Public Health Code
Patients with long term by steroids or other anti-inflammatory drugs
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Maud Boucherie, CRA
Email
maud.boucherie@covidien.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jean-Louis pepin, Pr
Organizational Affiliation
University Hospital, Grenoble
Official's Role
Principal Investigator
Facility Information:
Facility Name
Laboratoire d'Explorations Fonctionnelles Cardio-Respiratoires - CHU Grenoble
City
Grenoble
State/Province
Cedex 9
ZIP/Postal Code
38043
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jean-Louis Pepin, Pr
Email
JLPepin@chu-grenoble.fr
First Name & Middle Initial & Last Name & Degree
Jean-Christian Borel
Email
JCBorel@chu-grenoble.fr
12. IPD Sharing Statement
Citations:
PubMed Identifier
21885724
Citation
Borel JC, Tamisier R, Gonzalez-Bermejo J, Baguet JP, Monneret D, Arnol N, Roux-Lombard P, Wuyam B, Levy P, Pepin JL. Noninvasive ventilation in mild obesity hypoventilation syndrome: a randomized controlled trial. Chest. 2012 Mar;141(3):692-702. doi: 10.1378/chest.10-2531. Epub 2011 Sep 1.
Results Reference
derived
PubMed Identifier
19701463
Citation
Borel JC, Roux-Lombard P, Tamisier R, Arnaud C, Monneret D, Arnol N, Baguet JP, Levy P, Pepin JL. Endothelial dysfunction and specific inflammation in obesity hypoventilation syndrome. PLoS One. 2009 Aug 24;4(8):e6733. doi: 10.1371/journal.pone.0006733.
Results Reference
derived
Learn more about this trial
Use of Polysomnography for Non-Invasive Ventilation Settings' Optimization
We'll reach out to this number within 24 hrs